The risk of tumorigenesis, the threshold concentration of TAA needed for stimulation, and the presence of immunosuppressive cytokines such as IL-10 and TGF-β that can offset proper anti-tumor response preclude the wide use of tumor lysates for vaccination [50]. This evidence concerns the gene TGFB1 and neoplasm.